Pantherna Therapeutics
PrivateLast Round
Follow-on Offering
Jan 11, 2022
Total Funding Raised
$11.17M
Company Overview
Pantherna Therapeutics is a biotechnology company developing first-in-class mRNA therapeutics for vascular diseases using its proprietary nanoparticle delivery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pantherna Therapeutics Comparables
Compare Pantherna Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ethris | 86% | |
| eTheRNA | 85% | |
| SML BIOPHARM | 82% | |
Pantherna Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Jan 11, 2022 | ||||
| Grant | May 28, 2021 | ||||
| Seed | Jul 3, 2019 |
Key People
Founding team and executive leadership
Pantherna Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Investment Fund | Seed |
| Brandenburg Kapital | Grant, Seed |
| European Union | Grant |
| High-Tech Gründerfonds | Seed, Follow-on Offering |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 10, 2025
Monthly visitors grew 100% MoM, reaching 1.4K.
- Jan 11, 2022
$4.5M round led by High-Tech Gründerfonds
Pantherna Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pantherna Therapeutics's valuation, stock price, and market status.